Tenofovir induced Fanconi syndrome: A possible pharmacokinetic interaction

Tenofovir was introduced as a second line drug for the treatment of human immunodeficiency virus (HIV) infection in India in December 2009. Although rare, renal toxicity is a recognized adverse drug reaction (ADR) of this drug, especially when administered with boosted lopinavir-ritonavir. In this c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapadia, Jigar, Shah, Samidh, Desai, Chetna, Desai, Mira, Patel, Shivani, Shah, Asha N., Dikshit, R. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660936/
https://www.ncbi.nlm.nih.gov/pubmed/23716900
http://dx.doi.org/10.4103/0253-7613.108319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660936/
https://www.ncbi.nlm.nih.gov/pubmed/23716900
http://dx.doi.org/10.4103/0253-7613.108319

Ejemplares similares